BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Çakici N, Sutterland AL, Penninx BWJH, Dalm VA, de Haan L, van Beveren NJM. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Brain Behav Immun 2020;88:547-58. [PMID: 32330592 DOI: 10.1016/j.bbi.2020.04.039] [Cited by in Crossref: 20] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Q, Sun T, Li D, Zhao Z, Li Y. The differences in serum C1q levels between first-episode patients with bipolar disorder and major depressive disorder. J Psychosom Res 2022;162:111042. [PMID: 36156342 DOI: 10.1016/j.jpsychores.2022.111042] [Reference Citation Analysis]
2 Ryan KM, Mcloughlin DM. Peripheral blood inflammatory markers in depression: Response to electroconvulsive therapy and relationship with cognitive performance. Psychiatry Research 2022;315:114725. [DOI: 10.1016/j.psychres.2022.114725] [Reference Citation Analysis]
3 Casas BS, Arancibia-altamirano D, Acevedo-la Rosa F, Garrido-jara D, Maksaev V, Pérez-monje D, Palma V. It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective. Front Cell Dev Biol 2022;10:946706. [DOI: 10.3389/fcell.2022.946706] [Reference Citation Analysis]
4 Skibinska M, Rajewska-rager A, Dmitrzak-weglarz M, Kapelski P, Lepczynska N, Kaczmarek M, Pawlak J. Interleukin-8 and tumor necrosis factor-alpha in youth with mood disorders—A longitudinal study. Front Psychiatry 2022;13:964538. [DOI: 10.3389/fpsyt.2022.964538] [Reference Citation Analysis]
5 Norman TR. Editorial: Role of the serotonergic system in pathology of major depressive disorders. Front Psychiatry 2022;13:988307. [DOI: 10.3389/fpsyt.2022.988307] [Reference Citation Analysis]
6 Lestra V, Romeo B, Martelli C, Benyamina A, Hamdani N. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis. Schizophr Res 2022;246:175-86. [PMID: 35785580 DOI: 10.1016/j.schres.2022.06.026] [Reference Citation Analysis]
7 Benros ME. High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis. Acta Psychiatr Scand 2022;146:3-5. [PMID: 35714064 DOI: 10.1111/acps.13458] [Reference Citation Analysis]
8 Qiao S, Zhang J, Chen S, Olatosi B, Hardeman S, Narasimhan M, Bruner L, Diedhiou A, Scott C, Mansaray A, Weissman S, Li X. How Different Pre-existing Mental Disorders and Their Co-occurrence Affects COVID-19 Clinical Outcomes? A Real-World Data Study in the Southern United States. Front Public Health 2022;10:831189. [DOI: 10.3389/fpubh.2022.831189] [Reference Citation Analysis]
9 Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Front Psychiatry 2022;13:880568. [PMID: 35546942 DOI: 10.3389/fpsyt.2022.880568] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhu ZH, Song XY, Man LJ, Chen P, Tang Z, Li RH, Ji CF, Dai NB, Liu F, Wang J, Zhang J, Jia QF, Hui L. Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls. Front Psychiatry 2022;13:858675. [DOI: 10.3389/fpsyt.2022.858675] [Reference Citation Analysis]
11 Singh D, Guest PC, Dobrowolny H, Vasilevska V, Meyer-Lotz G, Bernstein HG, Borucki K, Neyazi A, Bogerts B, Jacobs R, Steiner J. Changes in leukocytes and CRP in different stages of major depression. J Neuroinflammation 2022;19:74. [PMID: 35379263 DOI: 10.1186/s12974-022-02429-7] [Reference Citation Analysis]
12 Zhang D, Ji Y, Chen X, Chen R, Wei Y, Peng Q, Lin J, Yin J, Li H, Cui L, Lin Z, Cai Y. Peripheral Blood Circular RNAs as a Biomarker for Major Depressive Disorder and Prediction of Possible Pathways. Front Neurosci 2022;16:844422. [DOI: 10.3389/fnins.2022.844422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lin P, Sun J, Lou X, Li D, Shi Y, Li Z, Ma P, Li P, Chen S, Jin W, Liu S, Chen Q, Gao Q, Zhu L, Xu J, Zhu M, Wang M, Liang K, Zhao L, Xu H, Dong K, Li Q, Cheng X, Chen J, Guo X. Consensus on potential biomarkers developed for use in clinical tests for schizophrenia. Gen Psych 2022;35:e100685. [DOI: 10.1136/gpsych-2021-100685] [Reference Citation Analysis]
14 Chen X, Yao T, Cai J, Fu X, Li H, Wu J. Systemic inflammatory regulators and 7 major psychiatric disorders: A two-sample Mendelian randomization study. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110534. [PMID: 35150783 DOI: 10.1016/j.pnpbp.2022.110534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Hoshikawa T, Okamoto N, Natsuyama T, Fujii R, Ikenouchi A, Honma Y, Harada M, Yoshimura R. Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation. NDT 2022;Volume 18:173-86. [DOI: 10.2147/ndt.s350121] [Reference Citation Analysis]
16 Kittel-Schneider S, Davidova P, Kalok M, Essel C, Ahmed FB, Kingeter Y, Matentzoglu M, Leutritz AL, Kersken K, Koreny C, Weber H, Kollert L, McNeill RV, Reif A, Bahlmann F, Trautmann-Villalba P. A pilot study of multilevel analysis of BDNF in paternal and maternal perinatal depression. Arch Womens Ment Health 2022. [PMID: 34989854 DOI: 10.1007/s00737-021-01197-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Duong A, Jeong H, El Sabbagh DES, Andreazza AC. Systemic inflammatory biomarkers in DSM-5 defined disorders and COVID-19: Evidence from published meta-analyses. Biological Psychiatry Global Open Science 2022. [DOI: 10.1016/j.bpsgos.2022.01.006] [Reference Citation Analysis]
18 Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-mazur J, Mak M, Rek-owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110510] [Reference Citation Analysis]
19 Dawidowski B, Grelecki G, Biłgorajski A, Podwalski P, Misiak B, Samochowiec J. Effect of Antipsychotic Treatment on Neutrophil-to-Lymphocyte Ratio during Hospitalization for Acute Psychosis in the Course of Schizophrenia-A Cross-Sectional Retrospective Study. J Clin Med 2021;11:232. [PMID: 35011972 DOI: 10.3390/jcm11010232] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Chen MH, Wu HJ, Li CT, Lin WC, Tsai SJ, Hong CJ, Tu PC, Bai YM, Mao WC, Su TP. Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials. J Psychiatr Res 2021;144:448-54. [PMID: 34752941 DOI: 10.1016/j.jpsychires.2021.11.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Łoś K, Kulikowska J, Waszkiewicz N. First-Time Psychotic Symptoms in a Patient After COVID-19 Infection-A Case Report. Front Psychiatry 2021;12:726059. [PMID: 34721104 DOI: 10.3389/fpsyt.2021.726059] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Chen MH, Hsu JW, Huang KL, Tsai SJ, Tu PC, Bai YM. Inflammatory cytokines in and cognitive function of adolescents with first-episode schizophrenia, bipolar disorder, or major depressive disorder. CNS Spectr 2021;:1-8. [PMID: 34664544 DOI: 10.1017/S1092852921000857] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Piotrkowicz M, Janoska-Jazdzik M, Koweszko T, Szulc A. The Influence of Psychotherapy on Peripheral Brain-Derived Neurotrophic Factor Concentration Levels and Gene Methylation Status: A Systematic Review. J Clin Med 2021;10:4424. [PMID: 34640441 DOI: 10.3390/jcm10194424] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Maślińska M, Trędzbor B, Krzystanek M. Dysbiosis, gut-blood barrier rupture and autoimmune response in rheumatoid arthritis and schizophrenia. Reumatologia 2021;59:180-7. [PMID: 34538945 DOI: 10.5114/reum.2021.107588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dawidowski B, Górniak A, Podwalski P, Lebiecka Z, Misiak B, Samochowiec J. The Role of Cytokines in the Pathogenesis of Schizophrenia. J Clin Med 2021;10:3849. [PMID: 34501305 DOI: 10.3390/jcm10173849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
26 Han D, Sun D, Xiu M, Su X, Wang J, Li J, Wang D. Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up. Psychoneuroendocrinology 2021;133:105392. [PMID: 34428640 DOI: 10.1016/j.psyneuen.2021.105392] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Hoirisch-Clapauch S. Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis? Mol Psychiatry 2021. [PMID: 34404914 DOI: 10.1038/s41380-021-01264-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 De Giorgi R, Rizzo Pesci N, Quinton A, De Crescenzo F, Cowen PJ, Harmer CJ. Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies. Front Psychiatry 2021;12:702617. [PMID: 34385939 DOI: 10.3389/fpsyt.2021.702617] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
29 Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, Lancon C, Auquier P, Baumstarck K, Llorca PM, Yon DK, Boyer L. Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis. JAMA Psychiatry 2021. [PMID: 34313711 DOI: 10.1001/jamapsychiatry.2021.2274] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
30 Wang L, Yin Y, Zhou Y, Huang J, Zhang P, Chen S, Fan H, Cui Y, Luo X, Tan S, Wang Z, Li CR, Tian B, Tian L, Elliot Hong L, Tan Y. The mediating effect of brain-derived neurotrophic factor levels on childhood trauma and psychiatric symptoms in patients with first-episode schizophrenia. Aust N Z J Psychiatry 2021;:48674211031478. [PMID: 34263656 DOI: 10.1177/00048674211031478] [Reference Citation Analysis]
31 Wu S, Zhou Y, Xuan Z, Xiong L, Ge X, Ye J, Liu Y, Yuan L, Xu Y, Ding G, Xiao A, Guo J, Yu L. Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study. Sci Rep 2021;11:13365. [PMID: 34183728 DOI: 10.1038/s41598-021-92807-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Forbes MP, O'Neil A, Lane M, Agustini B, Myles N, Berk M. Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression. Drugs Aging 2021;38:451-67. [PMID: 33913114 DOI: 10.1007/s40266-021-00858-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Tang W, Liu H, Chen L, Zhao K, Zhang Y, Zheng K, Zhu C, Zheng T, Liu J, Wang D, Yu L, Fang X, Zhang C, Su KP. Inflammatory cytokines, complement factor H and anhedonia in drug-naïve major depressive disorder. Brain Behav Immun 2021;95:238-44. [PMID: 33794316 DOI: 10.1016/j.bbi.2021.03.022] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
34 Çakici N, Sutterland AL, Penninx BWJH, de Haan L, van Beveren NJM. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Psychol Med 2021;51:538-49. [PMID: 33653423 DOI: 10.1017/S0033291721000155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
35 Tsai S. Role of interleukin 8 in depression and other psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;106:110173. [DOI: 10.1016/j.pnpbp.2020.110173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
36 Fujita Y, Hashimoto Y, Hashimoto H, Chang L, Hashimoto K. Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling. Eur J Pharmacol 2021;897:173954. [PMID: 33617822 DOI: 10.1016/j.ejphar.2021.173954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Chen D, Li H, Zhao Q, Song J, Lin C, Yu J. Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naïve first-episode schizophrenia. Psychiatry Res 2021;297:113717. [PMID: 33503523 DOI: 10.1016/j.psychres.2021.113717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Branchi I, Poggini S, Capuron L, Benedetti F, Poletti S, Tamouza R, Drexhage HA, Penninx BWJH, Pariante CM; European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group and Marion Leboyer. Brain-immune crosstalk in the treatment of major depressive disorder. Eur Neuropsychopharmacol 2021;45:89-107. [PMID: 33386229 DOI: 10.1016/j.euroneuro.2020.11.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
39 Zhou Y, Song X, Guo Y, Lang X, Li Z, Zhang XY. Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. Psychoneuroendocrinology 2021;124:105061. [PMID: 33291004 DOI: 10.1016/j.psyneuen.2020.105061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
40 Scorza FA, de Almeida AG, Scorza CA, Cysneiros RM, Rodrigues AM, Finsterer J. Interleukin-6 in schizophrenia: Cause of death matters. Brain Behav Immun 2020;90:381-2. [PMID: 32889081 DOI: 10.1016/j.bbi.2020.08.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Çakici N, Sutterland AL, Penninx BWJH, de Haan L, van Beveren NJM. Reply to interleukin-6 in schizophrenia: Cause of death matters. Brain Behav Immun 2020;90:383-4. [PMID: 32889080 DOI: 10.1016/j.bbi.2020.08.032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]